全球 Hedgehog 通路抑制剂市场 – 行业趋势和 2029 年预测

 市场分析和规模

近年来，预计 Hedgehog 通路抑制剂市场将在预测期内快速增长。根据美国癌症协会 (ACS) 的数据，全球每年有 540 万人被诊断出患有鳞状细胞和基底细胞皮肤癌，其中 330 万人患上鳞状细胞皮肤癌，超过 80% 的人口患上基底细胞癌。预计癌症病例的增加将影响预测期内市场的扩张。由于对无痛治疗的需求不断增长，Hedgehog 通路抑制剂比传统的癌症治疗更受欢迎。所有这些因素导致医疗保健行业对 Hedgehog 通路抑制剂的需求很高。

Data Bridge Market Research 分析称，Hedgehog 通路抑制剂市场在 2021 年的价值为 5.3139 亿美元，预计到 2029 年将达到 8.4058 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 5.90%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

市场定义

Hedgehog 通路抑制剂是一种小分子，属于一种新型治疗药物家族，主要针对参与 Hedgehog 通路调节的蛋白质。这些蛋白质是控制细胞分化和参与器官形成的蛋白质家族，已证明可以增强成人干细胞增殖。Hedgehog 信号通路的错误激活可导致肺癌、前列腺癌、胰腺癌、乳腺癌、脑癌、皮肤癌等癌症的进展。

报告范围和市场细分

Hedgehog Pathway Inhibitors? Market Dynamics

Drivers

• Increasing prevalence of basal cell carcinoma and acute myeloid leukaemia

The rising prevalence of basal cell carcinoma and acute myeloid leukaemia is anticipated to influence the hedgehog pathway inhibitors? market's growth. Chronic infections, a history of skin cancer, exposure to specific chemicals, skin inflammations, smoking, and UV exposure are all risk factors for basal cell carcinoma and acute myeloid leukaemia. Basal cell carcinoma and acute myeloid leukaemia are more common as a result of these risk factors. Consequently, the hedgehog pathway inhibitors market is expected to rise throughout the forecast period.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of hedgehog pathway inhibitors? market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the hedgehog pathway inhibitors? market. Additionally, high disposable income and sedentary lifestyle of people will result in the expansion of hedgehog pathway inhibitors? market. Along with this, rising geriatric population and favourable reimbursement policies will enhance the growth rate of the market.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the hedgehog pathway inhibitors? market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the hedgehog pathway inhibitors? market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the drug development and distribution? will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the hedgehog pathway inhibitors? market. Additionally, side effects of hedgehog pathway inhibitors? will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This hedgehog pathway inhibitors? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hedgehog pathway inhibitors? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Hedgehog pathway inhibitors? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Hedgehog Pathway Inhibitors? Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations therefore as consequence of multiple precautionary lockdowns and other limitations imposed by governments all over the world. The hedgehog pathway inhibitors market is no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors are likely to have a negative impact on the hedgehog pathway inhibitors market's revenue trajectory.

Global Hedgehog Pathway Inhibitors Market Scope

The hedgehog pathway inhibitors? market is segmented on the basis of drug, application, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug

• Daurismo
• Erivedge
• Odomzo
• Other

Application

• Basal Cell Carcinoma (BCC)
• Acute Lymphoblastic Leukemia (AML)
• Others

Dosage

• Injection
• Capsule
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Hedgehog Pathway Inhibitors Market Regional Analysis/Insights

The Hedgehog pathway inhibitors? market is analysed and market size insights and trends are provided by country, drug, application, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Hedgehog pathway inhibitors? market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the hedgehog pathway inhibitors? market because of the rising prevalence of basal cell carcinoma and acute myeloid leukaemia in this region. Additionally, growing presence of major key players will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to rising healthcare expenditure and improvements in healthcare infrastructure in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Hedgehog Pathway Inhibitors Market Share Analysis

Hedgehog 通路抑制剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对 Hedgehog 通路抑制剂市场的关注有关。

在 Hedgehog 通路抑制剂市场运营的一些主要参与者包括：

• 辉瑞公司（美国）
• 诺华公司（瑞士）
• 雅培（美国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• 赛诺菲（法国）
• 太阳制药工业有限公司 (印度)
• Inhibitor Therapeutics, Inc.（美国）
• MAX BioPharma（美国）
• Mayne Pharma Group Limited（澳大利亚）
• PellePharm Inc.（美国）     

SKU-68097